Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
DTIL from an elliott wave perspective has completed wave 2. Consolidation here would be good for an enentual wave 3. The projected zones are optimistic and it could easily take longer for the stock to move that far upward. I expect resistance around each target point which could cause consolidation, but hopefully from a long standpoint the stock could hit ATH by...
I am very bullish on DTIL biotech stock. Weekly curve seems to be back to test it. Growinf at a fast pace on the weekly chart. Structure still holding. Targets of 23$
I like DTIL to keep coiling for a possible breakout. I think a double bounce has more upside potential resulting in a late March 20PT whereas a shorter breakout could still give a 19PT by mid March. Either way I want to see it take back the 21EMA today or monday to instill confidence.
If we break the current support, likely down leg to lower upward trend. I will likely bow out and re-buy at the lower level. If we break above current support, will likely add to my holdings as I have done previously at this level. This is a speculative trade based on potential future benefit, so do what you will with it.
This is one of those companies where the fundamentals match the chart. This company is bringing gene editing to cancer and biodevelopment. The leading diagonal is super promising to have a strong first wave that would finish at ATH. After the Fib correction this could fly outside the pitchfork and really show longterm growth. Price targets on the next two waves...
Not much to say here other than bio stocks are the place to be. Historically there is plenty of headroom on this stock. I bought in around $9 and yes I wish I bought more. ATH is $23.60 - although very very briefly. In the meantime, I need to figure out some better charting for this one. Wait for the test and continuation up on this one. It has been such a long...
I typically post about what I'm actively trading, so I don't know how I forgot to mention this little gem. Precision biosciences is in the gene editing space with a relatively small market cap compared to others in the space (e.g. CRSPR). The company outlook is great in my opinion. It's one of my core stock picks for the year and largest holdings. My first...
Precision Biosciences (and Crispr as well) both recovered into an area of resistance - but have not yet proved they are back on track. I am long on both and if we strike further down will be accumulating. FWIW, I am looking at both being very strong in the spring - but at this point there is high risk.
I set a tight stop on DTIL at 12.96 having seen some decent profit. It's hard to establish trendlines on this one but if we test as support and continue back up I will re-enter.
Expecting a 15-17% Swing on DTIL as the stock rounds off from it's previous $12.50 Breakout Consolidation. It seems as though profit-taking has completed and the stock is moving higher in the pre-market session to solidify the swing trade. We have been watching the stock for the past few days and the Buying Volume has spiked over the course of that time period. In...
Putting this one out there for those that are interested. I am not advising one way or the other.
Off 18% at the time of this note. Hit a prior area of consolidation. Likely moving through this level and on to the next lower support line before a reversal.
LONG touch the resistance and have the potential to rise.
DTIL has been gaining of late inside of the small BLUE rising channel. As unassuming as it may look, this 3 month uptrend has already broken through a couple nasty resistance lines: the upper boundary of the RED falling channel, and the horizontal resistance of the BLACK rising triangle. If DTIL can trade above the 200 dma (4% above current price), then it could...
Alert set for break above $9.10 of possible long entry . 200ma and .236 Fib resistance to breakout Indicators bullish with room to run much higher Company Profile Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics...
DTIL is now trading above its supporting moving averages. The MACD is trending higher and Volume is coming up. the 200 sma looms above as resistance but I like this one.
This stock is high risk but carries a lot of potential. The structure is a textbook play.